Literature DB >> 23839567

Multiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.

Can Peng1, Matthew R Kimbrell, Chengju Tian, Thomas F Pack, Peter A Crooks, E Kim Fifer, Roger L Papke.   

Abstract

Positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptors can enhance ion channel currents and downstream effects of α7 stimulation. We investigated the approach of using noncompetitive antagonists to regulate α7 receptor function, potentially distinguishing effects requiring ion channel currents from signaling induced by nonconducting states. Three small readily reversible antagonists, (1S,2R,4R)-N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine (mecamylamine), N-(2.6-dimethylphenylcarbamoylmethyl)triethylammonium bromide (QX-314), and 2-(dimethylamino)ethyl 4-(butylamino)benzoate (tetracaine), as well as three large slowly reversible antagonists, bis-(2,2,6,6-tetramethyl-4-piperidinyl) sebacate (BTMPS), 2,2,6,6-tetramethylpiperidin-4-yl heptanoate (TMPH), and 1,2,4,5-tetra-{5-[1-(3-benzyl)pyridinium]pent-1-yl}benzene tetrabromide (tkP3BzPB), were investigated for their effectiveness and voltage dependence in the inhibition of responses evoked by acetylcholine alone or augmented by the α7-selective PAM N-(5-chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596). Analyses of the small antagonists on PNU-120596-potentiated single-channel bursts indicated that each agent had a distinct mechanism of inhibition and only that of QX-314 was consistent with simple open channel block. In addition to decreasing channel open times and burst durations, mecamylamine and tetracaine induced unique subconductance states. To determine whether channel-blocking activity alone would be sufficient to prevent cell death, the antagonists were tested for their ability to protect α7-expressing cells from cytotoxic effects of the α7 agonist choline in combination with PNU-120596. Only tetracaine and tkP3BzPB, the two agents that had effects least consistent with simple ion channel block, were fully cytoprotective at concentrations that gave submaximal inhibition of macroscopic currents in oocytes. Further analyses indicated that toxicity produced by PNU-120596 and choline was calcium independent and likely an apoptotic event. Our results are consistent with the hypothesis that PAMs may modulate conformational states important for both channel activity and ion channel-independent signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23839567      PMCID: PMC3876815          DOI: 10.1124/mol.113.086462

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  33 in total

1.  A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.

Authors:  Raymond S Hurst; Mihaly Hajós; Mario Raggenbass; Theron M Wall; Nicole R Higdon; Judy A Lawson; Karen L Rutherford-Root; Mitchell B Berkenpas; W E Hoffmann; David W Piotrowski; Vincent E Groppi; Geraldine Allaman; Roch Ogier; Sonia Bertrand; Daniel Bertrand; Stephen P Arneric
Journal:  J Neurosci       Date:  2005-04-27       Impact factor: 6.167

2.  Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB.

Authors:  Mario B Marrero; Merouane Bencherif
Journal:  Brain Res       Date:  2008-11-27       Impact factor: 3.252

3.  Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.

Authors:  Gareth T Young; Ruud Zwart; Alison S Walker; Emanuele Sher; Neil S Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-12       Impact factor: 11.205

4.  Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

5.  Muscle-type nicotinic acetylcholine receptor delta subunit determines sensitivity to noncompetitive inhibitors, while gamma subunit regulates divalent permeability.

Authors:  M M Francis; R L Papke
Journal:  Neuropharmacology       Date:  1996       Impact factor: 5.250

6.  Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor.

Authors:  R J Leonard; C G Labarca; P Charnet; N Davidson; H A Lester
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

7.  The effects of subunit composition on the inhibition of nicotinic receptors by the amphipathic blocker 2,2,6,6-tetramethylpiperidin-4-yl heptanoate.

Authors:  Roger L Papke; Joshua D Buhr; Michael M Francis; Kyung Il Choi; Jeffrey S Thinschmidt; Nicole A Horenstein
Journal:  Mol Pharmacol       Date:  2005-03-10       Impact factor: 4.436

8.  Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.

Authors:  Jens Halvard Grønlien; Monika Håkerud; Hilde Ween; Kirsten Thorin-Hagene; Clark A Briggs; Murali Gopalakrishnan; John Malysz
Journal:  Mol Pharmacol       Date:  2007-06-12       Impact factor: 4.436

9.  Inhibition of nicotinic acetylcholine receptors by bis (2,2,6,6-tetramethyl- 4-piperidinyl) sebacate (Tinuvin 770), an additive to medical plastics.

Authors:  R L Papke; A G Craig; S F Heinemann
Journal:  J Pharmacol Exp Ther       Date:  1994-02       Impact factor: 4.030

10.  Voltage- and Temperature-Dependent Allosteric Modulation of α7 Nicotinic Receptors by PNU120596.

Authors:  Fabrio Sitzia; Jon T Brown; Andrew D Randall; John Dunlop
Journal:  Front Pharmacol       Date:  2011-12-27       Impact factor: 5.810

View more
  14 in total

1.  A mutation in the extracellular domain of the α7 nAChR reduces calcium permeability.

Authors:  José O Colón-Sáez; Jerrel L Yakel
Journal:  Pflugers Arch       Date:  2013-11-01       Impact factor: 3.657

2.  Macroscopic and Microscopic Activation of α7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107.

Authors:  Marta Quadri; Sumanta Garai; Ganesh A Thakur; Clare Stokes; Alican Gulsevin; Nicole A Horenstein; Roger L Papke
Journal:  Mol Pharmacol       Date:  2018-10-22       Impact factor: 4.436

3.  Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.

Authors:  Roger L Papke; Clare Stokes; M Imad Damaj; Ganesh A Thakur; Khan Manther; Millet Treinin; Deniz Bagdas; Abhijit R Kulkarni; Nicole A Horenstein
Journal:  Br J Pharmacol       Date:  2017-06-08       Impact factor: 8.739

Review 4.  Merging old and new perspectives on nicotinic acetylcholine receptors.

Authors:  Roger L Papke
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

5.  The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.

Authors:  Roger L Papke; Nicole A Horenstein; Abhijit R Kulkarni; Clare Stokes; Lu W Corrie; Cheol-Young Maeng; Ganesh A Thakur
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

6.  Allosterically Potentiated α7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium.

Authors:  Douglas R Miller; Habibeh Khoshbouei; Sumanta Garai; Lucas N Cantwell; Clare Stokes; Ganesh Thakur; Roger L Papke
Journal:  Mol Pharmacol       Date:  2020-10-05       Impact factor: 4.436

Review 7.  Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.

Authors:  Darlene H Brunzell; J Michael McIntosh; Roger L Papke
Journal:  Ann N Y Acad Sci       Date:  2014-04-14       Impact factor: 5.691

8.  Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors.

Authors:  Nathan D Schilaty; David M Hedges; Eun Young Jang; Ryan J Folsom; Jordan T Yorgason; J Michael McIntosh; Scott C Steffensen
Journal:  J Pharmacol Exp Ther       Date:  2014-03-18       Impact factor: 4.030

9.  Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site.

Authors:  Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Clelia Dallanoce; Ganesh A Thakur; Roger L Papke
Journal:  Eur J Pharmacol       Date:  2021-05-15       Impact factor: 5.195

Review 10.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.